JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuman, W. F.
Right arrow Articles by Allen, R. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Neuman, W. F.
Right arrow Articles by Allen, R. P.
Journal of Pharmacology And Experimental Therapeutics, Vol. 96, Issue 1, 95-98, 1949
Copyright © 1949 by American Society for Pharmacology and Experimental Therapeutics


THE FAILURE OF 2,3 DITHIOPROPANOL (BAL) TO AFFECT ACUTE, SYSTEMIC URANIUM POISONING

W. F. Neuman 1 and R. P. Allen 1

1 Division of Pharmacology and Toxicology of Department of Radiation Biology, Univercity of Rochester School of Medicine and Dentistry, Rochester, New York

1. Albino rats were systemically poisoned with 3.0 mgm./kgm. of HgCl2 I.P., and successfully treated with BAL as late as 30 minutes after the administration of Hg.

2. Studies were made of the effect of BAL on the toxic effects of three uranium compounds (UO2(NO3)2·6H2O, UO2F2 and UCl4) parenterally administered to albino rats with negative results.

3. The negative results were taken as confirmatory evidence for the view that uranium exerts its toxic effects primarily by some other means than a combination with —SH groups.

Submitted on January 27, 1949







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1949 by the American Society for Pharmacology and Experimental Therapeutics.